BCR-ABL1 Mutation Analysis

When standard leukemia therapies stop working, securing an accurate molecular profile of your condition offers invaluable peace of mind and a renewed direction for care. As part of our Molecular Diagnostics division, our BCR-ABL1 Mutation Analysis employs cutting-edge DNA sequencing to evaluate specific resistance markers within the leukemia fusion gene. Rather than providing an isolated clinical diagnosis, this essential BCR-ABL1 mutation analysis data serves as a vital tool for your hematologist, shaping highly targeted, alternative medical guidance and therapy adjustments. Trusted as one of the leading diagnostic labs in the UAE, DNA Labs UAE guarantees uncompromising patient confidentiality and consistently rapid, precise turnaround times. Take a proactive step for your ongoing oncology wellness: review our BCR-ABL1 mutation analysis in the UAE below to book an appointment, schedule a gentle home collection, or consult our dedicated experts.